HemoHIM ameliorates the persistent down-regulation of Th1-like immune responses in fractionated γ-irradiated mice by modulating the IL-12p70-STAT4 signaling pathway

Radiat Res. 2012 May;177(5):676-84. doi: 10.1667/rr2768.1. Epub 2012 Apr 2.

Abstract

Whole body irradiated mice appear to experience a down-regulation of the helper T (Th)1-like immune response, and maintain a persistent immunological imbalance. In the current study, we evaluated the effect of HemoHIM (an herbal product made from Angelica Radix, Cnidium officinale , and Paeonia japonica cultivated in Korea) to ameliorate the immunological imbalance induce in fractionated γ-irradiated mice. The mice were exposed to γ rays twice a week (0.5 Gy fractions) for a total dose of 5 Gy, and HemoHIM was administrated orally from 1 week before the first irradiation to 1 week before the final analysis. All experiments were performed 4 and 6 months after their first exposure. HemoHIM ameliorated the Th1- and Th2-related immune responses normally occur in irradiated mice with or without dinitrophenylated keyhole limpet hemocyanin immunization. HemoHIM also restored the natural killer cell activities without changing the percentage of natural killer cells in irradiated mice. Furthermore, the administration of HemoHIM prevented the reduction in levels of interleukin-12p70 in irradiated mice. Finally, we found that HemoHIM enhanced the phosphorylation of signal transducer and activator of transcription (STAT) 4 that was reduced in irradiated mice. Our findings suggest that HemoHIM ameliorates the persistent down-regulation of Th1-like immune responses by modulating the IL-12p70/pSTAT4 signaling pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibody Formation / drug effects
  • Antibody Formation / radiation effects
  • Cytotoxicity, Immunologic / drug effects
  • Cytotoxicity, Immunologic / radiation effects
  • Dose Fractionation, Radiation
  • Down-Regulation / drug effects
  • Drug Evaluation, Preclinical
  • Female
  • Gamma Rays / adverse effects*
  • Immunization
  • Immunologic Deficiency Syndromes / etiology
  • Immunologic Deficiency Syndromes / prevention & control*
  • Interleukin-12 / physiology*
  • Killer Cells, Natural / drug effects*
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / radiation effects
  • Lymphokines / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Phosphorylation / drug effects
  • Phytotherapy*
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Protein Processing, Post-Translational / drug effects
  • Radiation Injuries, Experimental / drug therapy*
  • Radiation Injuries, Experimental / immunology
  • Radiation-Protective Agents / pharmacology
  • Radiation-Protective Agents / therapeutic use*
  • STAT4 Transcription Factor / physiology*
  • Signal Transduction / drug effects*
  • Specific Pathogen-Free Organisms
  • Spleen / immunology
  • Spleen / pathology
  • Spleen / radiation effects
  • Th1 Cells / drug effects*
  • Th1 Cells / metabolism
  • Th1 Cells / radiation effects
  • Th2 Cells / drug effects
  • Th2 Cells / metabolism
  • Th2 Cells / radiation effects
  • Whole-Body Irradiation / adverse effects*

Substances

  • HemoHIM
  • Lymphokines
  • Plant Extracts
  • Radiation-Protective Agents
  • STAT4 Transcription Factor
  • Stat4 protein, mouse
  • Interleukin-12